Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Strategic Alliance

11 Feb 2015 07:00

RNS Number : 5724E
Tekcapital plc
11 February 2015
 

11 February 2015

 

Tekcapital Plc

 

("Tekcapital", "the Company" or "the Group")

 

Tekcapital Announces a Strategic Alliance with Health Connexions™

 

 

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, is pleased to announce it has entered into a strategic alliance with Health Connexions™, to market InventionEvaluator more widely to pharmaceutical, medical device, diagnostic and healthcare companies.

 

InventionEvaluator, a division of Tekcapital, provides in-depth analytical reports that assess the commercial potential of new technologies and intellectual property, thereby enabling clients to make more informed decisions regarding investments in new technologies. As part of the Alliance, Health Connexionswill make the InventionEvaluator's reports available to its clients and network members worldwide.

 

Through the acquisition of InventionEvaluator (www.inventionevaluator.com), announced on the 23rd of July, 2014, Tekcapital has added an important additional service for clients, who are able to use this product to further determine and extract value from intellectual property.

 

Health Connexions™ is a Boston-based professional services firm with a global reach that provides Strategic Consulting, Market Research, Communications, Education & Training, and Care & Cost Management to healthcare, pharmaceutical, diagnostic and medical device companies (www.healthconnexions.com).

 

Commenting on the announcement, Dr. Clifford M. Gross, Executive Chairman of Tekcapital plc said:

 

"The acquisition of InventionEvaluator has expanded our service offering and client base. To further expand its market penetration into life science and health care companies, we are very excited to have entered into a strategic alliance with Health Connexions™. We believe their large network of leading companies focused on improving medical outcomes is an excellent fit with InventionEvaluator's reports, which provide guidance on the marketability of newly developed technologies."

Commenting on the announcement, Dawn Van Dam, President & CEO of Health Connexions™ said:

 

"We are very enthusiastic to be able to provide the InventionEvaluator service to our clients worldwide. Health Connexions™ has developed an extensive network and unique collaborative model in consulting & market research, technology evaluations and marketing communications services to help clients in the life sciences and health care sectors transform science into commercial success. We believe that InventionEvaluator's comprehensive and cost-effective reports, which assess the marketability of new technologies, should prove valuable to many of our clients."

 

For further information please contact:

 

Tekcapital Plc

+1 305 200 3450 Ext 305

Clifford M. Gross, Ph.D., Executive Chairman

cgross@tekcapital.com

 

 

Health Connexions™

+1 416-402-8274

Dawn Van Dam, President & CEO

dawn.vandam@healthconnexions1.com

 

 

Northland Capital Partners Limited (NOMAD & Broker)

+44 (0) 20 7382 1100

William Vandyk (Corporate Finance)

wvandyk@northlandcp.co.uk

John Howes / Alice Lane (Corporate Broking)

 

 

 

Optiva Securities Limited (Co-Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

 

 

FTI Consulting, LLP

+44 (0) 20 3727 1000

Chris Lane / Emma Appleton / Roger Newby

tekcapital@fticonsulting.com

 

   

 

About Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 3,300+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

 

About Health Connexions, Inc. - Transforming Science into Commercial Success

 

Health Connexions™ works to accelerate the evaluation, adoption and commercialization of new technologies in life sciences, health care and consumer products. With an extensive network of over 5 million contacts, clients can profit from these connections and expertise garnered over the last 15 years. We also provide strategic advisory services around raising capital to fund new opportunities, or to support the growth of established organizations, by connecting capital and science to optimize ROI. For more information, please visit www.healthconnexions.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SALPKKDBOBKDDBD
Date   Source Headline
27th May 20267:00 amRNSResults for Year Ended 31 December 2025
22nd May 20267:00 amRNSTekcapital takes stake in geothermal AI firm
21st May 20267:00 amRNSNew Orders
28th Apr 20267:00 amRNSStrategic Resale Alliance with Cardinal IP
18th Feb 20267:00 amRNSNotification of Major Holdings
10th Feb 20267:00 amRNSConditional Placing of £1.5 million
15th Jan 20267:00 amRNSCorporate Update
7th Jan 20267:00 amRNS-RPorfolio Company Update - Innovative Eyewear Inc
12th Dec 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear Inc
1st Dec 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
19th Nov 20257:00 amRNSPortfolio Company Update - Guident Corp
13th Nov 20257:00 amRNSInnovative Eyewear Q3 Unaudited Financial Results
13th Nov 20257:00 amRNSTrading Statement
10th Nov 20257:00 amRNS-RStrategic Alliance signed with Nexscient Inc
4th Nov 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
17th Oct 20254:15 pmRNSNotification of Major Holdings
13th Oct 20251:44 pmRNSPlacing of £0.37 Million
10th Oct 20257:00 amRNSNew Product Launch – Invention Validator
8th Oct 202510:53 amRNSReplacement - Unaudited Half-Yearly Report
7th Oct 20257:00 amRNS-RPortfolio Company Update Innovative Eyewear
6th Oct 20257:00 amRNSReplacement RNS: Half-year Report
30th Sep 20257:02 amRNSCommercial Strategy Update & New Products
30th Sep 20257:00 amRNSHalf-year Report
25th Sep 20257:00 amRNS-RPortfolio Company Update -Guident
24th Sep 20257:00 amRNSUnaudited Half Yearly Report
18th Sep 20257:00 amRNSPortfolio Company Update -Guident Proposed US IPO
10th Sep 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
29th Aug 20257:00 amRNS-RPortfolio Company Update Guident Corp
19th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
15th Aug 20257:00 amRNS-RPortfolio Company Update Innovative Eyewear Q2
13th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
6th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
25th Jul 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNS-RPortfolio Company Update - Guident Corp
21st Jul 20257:00 amRNS-RPortfolio Company Update- Innovative Eyewear
27th Jun 202512:39 pmRNSResult of AGM
19th Jun 20251:06 pmRNSNotification of Major Holdings
19th Jun 202511:07 amRNSHolding(s) in Company - Replacement
19th Jun 20257:00 amRNS-RPortfolio Company Update - Guident Corp
10th Jun 20257:00 amRNSContract Win
2nd Jun 20257:02 amRNSNotice of AGM
2nd Jun 20257:00 amRNSFinal Results Year Ended 31 December Notice of AGM
2nd Jun 20257:00 amRNSFundraising of £1.25 Million
29th May 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear Inc
23rd May 20257:00 amRNSFinal Results Year Ended 31 December 2024
16th May 20257:00 amRNS-RPortfolio Company Update - Guident Corp
12th May 20257:00 amRNSPortfolio Company Update:Guident Corp Proposed IPO
6th May 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc.
28th Apr 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc
24th Apr 20257:00 amRNSQ1 2025 Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.